BAX RSI Chart
Last 7 days
-10.5%
Last 30 days
-15.2%
Last 90 days
-8.3%
Trailing 12 Months
-20.8%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 14.9B | 0 | 0 | 0 |
2023 | 14.5B | 14.6B | 14.7B | 14.8B |
2022 | 12.8B | 13.3B | 13.6B | 14.5B |
2021 | 11.8B | 12.2B | 12.5B | 12.1B |
2020 | 11.5B | 11.4B | 11.5B | 11.7B |
2019 | 11.0B | 11.1B | 11.2B | 11.4B |
2018 | 10.8B | 11.0B | 11.0B | 11.1B |
2017 | 10.3B | 10.3B | 10.4B | 10.6B |
2016 | 9.9B | 10.1B | 10.1B | 10.2B |
2015 | 10.6B | 10.4B | 10.2B | 10.0B |
2014 | 14.1B | 13.3B | 12.3B | 10.7B |
2013 | 14.2B | 14.2B | 14.4B | 15.0B |
2012 | 14.0B | 14.0B | 14.0B | 14.2B |
2011 | 13.2B | 13.5B | 13.8B | 13.9B |
2010 | 12.7B | 12.7B | 12.8B | 12.8B |
2009 | 12.3B | 12.2B | 12.2B | 12.6B |
2008 | 0 | 11.6B | 12.0B | 12.3B |
2007 | 0 | 0 | 0 | 11.3B |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index
Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.
Returns of $10,000 invested in:
Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022
Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 06, 2024 | rosenbloom david s. | acquired | - | - | 53,584 | evp and general counsel |
Mar 06, 2024 | borzi james w | acquired | - | - | 33,341 | evp,chief supply chain officer |
Mar 06, 2024 | almeida jose e | acquired | - | - | 142,891 | chairman, ceo, president |
Mar 06, 2024 | knight heather | acquired | - | - | 107,168 | evp,group pres,med products |
Mar 06, 2024 | toth christopher a. | acquired | - | - | 119,076 | evp,group pres, kidney care |
Mar 06, 2024 | grade joel t. | acquired | - | - | 42,867 | evp and cfo |
Mar 06, 2024 | rasul reazur | acquired | - | - | 83,353 | evp,group pres, healthcare |
Mar 06, 2024 | stevens brian | acquired | - | - | 14,289 | svp, cao & controller |
Mar 06, 2024 | mason jeanne k | acquired | - | - | 47,630 | evp, chief hr officer |
Mar 06, 2024 | sonig alok | acquired | - | - | 83,353 | evp,group president, pharma |
Which funds bought or sold BAX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 06, 2024 | JOHN G ULLMAN & ASSOCIATES INC | added | 16.42 | 601,550 | 2,697,190 | 0.41% |
May 06, 2024 | FAGAN ASSOCIATES, INC. | new | - | 202,288 | 202,288 | 0.04% |
May 06, 2024 | DiNuzzo Private Wealth, Inc. | added | 8.33 | 184 | 1,112 | -% |
May 06, 2024 | GABLES CAPITAL MANAGEMENT INC. | sold off | -100 | -5,799 | - | -% |
May 06, 2024 | Integrated Advisors Network LLC | new | - | 386,289 | 386,289 | 0.02% |
May 06, 2024 | Sabal Trust CO | unchanged | - | 31,172 | 326,534 | 0.02% |
May 06, 2024 | TEXAS PERMANENT SCHOOL FUND CORP | added | 1.05 | 469,852 | 4,480,900 | 0.04% |
May 06, 2024 | ORG Partners LLC | reduced | -97.31 | -80,799 | 2,525 | -% |
May 06, 2024 | Empowered Funds, LLC | added | 194 | 886,349 | 1,278,440 | 0.02% |
May 06, 2024 | STONERIDGE INVESTMENT PARTNERS LLC | sold off | -100 | -5,000,000 | - | -% |
Unveiling Baxter International Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Baxter International Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 184.5B | 40.3B | 32.81 | 4.58 | ||||
BDX | 68.5B | 19.7B | 51.42 | 3.48 | ||||
ALGN | 21.6B | 3.9B | 46.66 | 5.51 | ||||
BAX | 18.4B | 14.9B | 6.95 | 1.24 | ||||
MID-CAP | ||||||||
ATR | 9.9B | 3.5B | 31.71 | 2.8 | ||||
HSIC | 9.1B | 12.5B | 23.5 | 0.73 | ||||
BIO | 8.2B | 2.7B | -12.81 | 3.06 | ||||
XRAY | 5.9B | 3.9B | -62.76 | 1.49 | ||||
AXNX | 3.4B | 387.1M | -215.76 | 8.88 | ||||
PDCO | 2.3B | 6.6B | 12.05 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.87 | 0.4 | ||||
ANIK | 420.5M | 166.7M | -5.09 | 2.52 | ||||
ANGO | 245.9M | 324.0M | -1.28 | 0.76 | ||||
APYX | 48.8M | 52.3M | -2.61 | 0.93 | ||||
AEMD | 3.4M | 3.7M | -0.27 | 0.89 |
Baxter International Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -7.5% | 3,592 | 3,885 | 3,708 | 3,707 | 3,513 | 3,745 | 3,609 | 3,594 | 3,558 | 2,876 | 3,226 | 3,098 | 2,946 | 3,181 | 2,972 | 2,718 | 2,802 | 3,039 | 2,851 | 2,834 | 2,638 |
Gross Profit | -5.8% | 1,387 | 1,472 | 1,117 | 1,111 | 1,275 | 1,388 | 1,045 | 1,371 | 1,262 | 1,021 | 1,321 | 1,233 | 1,145 | 1,191 | 1,195 | 1,038 | 1,163 | 1,298 | 1,230 | 1,153 | 1,080 |
S&GA Expenses | 5.1% | 1,027 | 978 | 1,002 | 964 | 1,010 | 899 | 941 | 970 | 1,052 | 863 | 680 | 675 | 627 | 650 | 601 | 590 | 628 | 666 | 627 | 641 | 601 |
R&D Expenses | 2.3% | 176 | 172 | 166 | 165 | 164 | 154 | 151 | 148 | 150 | 135 | 129 | 139 | 128 | 135 | 123 | 117 | 146 | 156 | 144 | 166 | 129 |
EBITDA Margin | 12.9% | 0.06* | 0.05* | 0.04* | -0.15* | -0.12* | -0.11* | -0.14* | 0.12* | 0.13* | 0.15* | 0.17* | 0.17* | - | - | - | - | - | - | - | - | - |
Interest Expenses | -6.8% | -78.00 | -73.00 | -128 | -124 | -117 | -117 | -104 | -89.00 | -85.00 | -75.00 | -50.00 | -34.00 | -34.00 | -38.00 | -39.00 | -36.00 | -21.00 | -20.00 | -13.00 | -20.00 | -18.00 |
Income Taxes | -51.7% | 77.00 | 160 | -223 | 10.00 | 25.00 | 11.00 | -54.00 | 34.00 | 21.00 | -58.00 | -1.00 | 91.00 | 51.00 | 39.00 | 56.00 | 42.00 | 45.00 | -204 | 106 | 13.00 | 44.00 |
Earnings Before Taxes | -44.8% | 116 | 210 | -172 | -183 | 70.00 | 122 | -3,045 | 219 | 94.00 | -78.00 | 451 | 392 | 351 | 210 | 415 | 289 | 378 | -223 | 481 | 326 | 386 |
EBT Margin | 61.5% | 0.00* | -0.01* | -0.01* | -0.21* | -0.18* | -0.18* | -0.21* | 0.05* | 0.07* | 0.09* | 0.11* | 0.11* | - | - | - | - | - | - | - | - | - |
Net Income | -84.9% | 37.00 | 245 | 2,508 | -141 | 44.00 | 181 | -2,937 | 252 | 71.00 | 238 | 450 | 298 | 298 | 168 | 356 | 246 | 332 | -23.00 | 369 | 313 | 342 |
Net Income Margin | -0.8% | 0.18* | 0.18* | 0.18* | -0.20* | -0.17* | -0.17* | -0.17* | 0.08* | 0.08* | 0.11* | 0.10* | 0.09* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -69.3% | 163 | 531 | 365 | 351 | 479 | 439 | 290 | 274 | 208 | 693 | 675 | 477 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -1.7% | 27,788 | 28,276 | 30,656 | 27,885 | 28,291 | 28,287 | 27,965 | 31,831 | 32,716 | 33,521 | 19,807 | 19,682 | 19,466 | 20,019 | 20,098 | 19,465 | 19,075 | 18,193 | 17,299 | 17,503 | 16,241 |
Current Assets | -2.1% | 9,400 | 9,600 | 12,034 | 8,205 | 8,099 | 8,011 | 7,810 | 7,882 | 8,173 | 8,872 | 8,167 | 8,004 | 7,856 | 8,411 | 9,033 | 8,566 | 8,333 | 7,503 | 7,210 | 7,229 | 6,060 |
Cash Equivalents | -5.1% | 3,030 | 3,194 | 5,788 | 1,722 | 1,673 | 1,718 | 1,601 | 1,852 | 2,294 | 2,951 | 3,258 | 3,136 | 3,182 | 3,736 | 4,359 | 4,085 | 4,110 | 3,335 | 3,009 | 2,934 | 1,902 |
Inventory | 5.8% | 2,988 | 2,824 | 2,873 | 2,897 | 2,922 | 2,679 | 2,675 | 2,663 | 2,548 | 2,453 | 2,025 | 2,065 | 2,017 | 1,916 | 1,988 | 1,905 | 1,694 | 1,653 | 1,715 | 1,756 | 1,743 |
Net PPE | -1.4% | 4,370 | 4,433 | 4,278 | 4,494 | 5,000 | 4,695 | 4,799 | 4,976 | 5,114 | 5,178 | 4,582 | 4,649 | 4,614 | 4,722 | 4,460 | 4,382 | 4,340 | 4,512 | 4,406 | 4,485 | 4,476 |
Goodwill | -1.3% | 6,430 | 6,514 | 6,407 | 6,418 | 6,868 | 6,452 | 6,639 | 9,644 | 9,816 | 9,418 | 3,098 | 3,148 | 1.00 | 3,217 | 3,094 | 3,052 | 2,961 | 3,030 | 2,847 | - | - |
Liabilities | -1.3% | 19,553 | 19,808 | 22,490 | 22,254 | 22,350 | 22,392 | 22,386 | 22,928 | 23,597 | 24,400 | 10,992 | 11,147 | 10,976 | 11,293 | 11,496 | 11,305 | 11,345 | 10,281 | 9,682 | 9,700 | 8,648 |
Current Liabilities | -2.1% | 6,365 | 6,503 | 6,209 | 5,765 | 4,760 | 4,745 | 3,708 | 3,916 | 3,890 | 4,236 | 3,441 | 3,344 | 3,187 | 3,333 | 3,422 | 2,880 | 3,036 | 3,230 | 2,611 | 2,557 | 3,276 |
Short Term Borrowings | - | - | - | 514 | 249 | 50.00 | 299 | 275 | 200 | 200 | 301 | 301 | 51.00 | - | - | - | 1.00 | 221 | 226 | - | 2.00 | 796 |
Long Term Debt | -0.3% | 11,092 | 11,130 | 14,067 | 14,306 | 15,278 | 15,232 | 16,153 | - | - | 17,149 | - | - | - | - | - | - | - | 4,809 | - | 5,157 | 3,451 |
Shareholder's Equity | -2.0% | 8,235 | 8,402 | 8,101 | 5,631 | 5,941 | 5,833 | 5,579 | 8,903 | 9,119 | 9,121 | 8,815 | 8,535 | 8,490 | 8,726 | 8,602 | 8,160 | 7,730 | 7,912 | 7,617 | 7,803 | 7,593 |
Retained Earnings | -0.7% | 16,003 | 16,114 | 16,015 | 13,655 | 13,947 | 14,050 | 14,015 | 17,099 | 16,994 | 17,065 | 16,967 | 16,658 | 16,502 | 16,328 | 16,285 | 16,055 | 15,935 | 15,718 | 15,849 | 15,598 | 15,414 |
Additional Paid-In Capital | -0.8% | 6,339 | 6,389 | 6,368 | 6,341 | 6,312 | 6,322 | 6,297 | 6,253 | 6,207 | 6,197 | 6,131 | 6,090 | 6,043 | 6,043 | 6,009 | 5,975 | 5,935 | 5,955 | 5,926 | 5,906 | 5,839 |
Shares Outstanding | 0.4% | 508 | 506 | 507 | 506 | 505 | 504 | 503 | 503 | 503 | 502 | 500 | 503 | - | - | - | - | - | - | - | - | - |
Minority Interest | -6.1% | 62.00 | 66.00 | 65.00 | 62.00 | 62.00 | 62.00 | 44.00 | 44.00 | 44.00 | 44.00 | 45.00 | 41.00 | 38.00 | 37.00 | 35.00 | 32.00 | 31.00 | 30.00 | 29.00 | 24.00 | 23.00 |
Float | - | - | - | - | 23,000 | - | - | - | 32,000 | - | - | - | 40,000 | - | - | - | 44,000 | - | - | - | 42,000 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -69.3% | 163 | 531 | 365 | 351 | 479 | 439 | 290 | 274 | 208 | 693 | 675 | 477 | 377 | 712 | 510 | 374 | 272 | 829 | 701 | 446 | 128 |
Share Based Compensation | -16.7% | 25.00 | 30.00 | 41.00 | 37.00 | 25.00 | 31.00 | 45.00 | 45.00 | 32.00 | 53.00 | 34.00 | 37.00 | 22.00 | 33.00 | 33.00 | 35.00 | 29.00 | 30.00 | 35.00 | 35.00 | 22.00 |
Cashflow From Investing | 27.8% | -166 | -230 | 3,786 | -173 | -170 | -256 | -184 | -187 | -304 | -10,267 | -207 | -188 | -538 | -264 | -157 | -154 | -604 | -421 | -231 | -147 | -301 |
Cashflow From Financing | 95.2% | -140 | -2,935 | -62.00 | -120 | -372 | -119 | -302 | -469 | -548 | 9,276 | -324 | -349 | -358 | -1,143 | -111 | -261 | 1,170 | -116 | -354 | 730 | 238 |
Dividend Payments | -100.0% | - | 147 | 147 | 146 | 146 | 146 | 146 | 141 | 140 | 140 | 141 | 124 | 125 | 125 | 125 | 112 | 111 | 113 | 112 | 97.00 | 101 |
Buy Backs | - | - | - | - | - | - | - | 32.00 | - | - | - | 35.00 | 312 | 253 | 500 | - | - | - | 241 | 309 | 123 | 597 |
Condensed Consolidated Statements of Income (unaudited) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Net sales | $ 3,592 | $ 3,513 |
Cost of sales | 2,205 | 2,238 |
Gross margin | 1,387 | 1,275 |
Selling, general and administrative expenses | 1,027 | 995 |
Research and development expenses | 176 | 164 |
Other operating income, net | (3) | (13) |
Operating income | 187 | 129 |
Interest expense, net | 78 | 117 |
Other income, net | 7 | 2 |
Income from continuing operations before income taxes | 116 | 14 |
Income tax expense | 77 | 14 |
Income from continuing operations | 39 | 0 |
Income from discontinued operations, net of tax | 0 | 45 |
Net income | 39 | 45 |
Less: Comprehensive income attributable to noncontrolling interests | 2 | 1 |
Net income attributable to Baxter stockholders | $ 37 | $ 44 |
Income from continuing operations per common share | ||
Income from continuing operations per common share, basic (in dollars per share) | $ 0.07 | $ (0.00) |
Income from continuing operations per common share, diluted (in dollars per share) | 0.07 | (0.00) |
Income from discontinued operations per common share | ||
Income from discontinued operations per common share, basic (in dollars per share) | 0.00 | 0.09 |
Income from discontinued operations per common share, diluted (in dollars per share) | 0.00 | 0.09 |
Net income per common share | ||
Basic (in dollars per share) | 0.07 | 0.09 |
Diluted (in dollars per share) | $ 0.07 | $ 0.09 |
Weighted-average number of shares outstanding | ||
Basic (in shares) | 508 | 505 |
Diluted (in shares) | 510 | 505 |
Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 3,026 | $ 3,194 |
Accounts receivable, net of allowances of $121 in 2024 and $129 in 2023 | 2,521 | 2,690 |
Inventories | 2,988 | 2,824 |
Prepaid expenses and other current assets | 865 | 892 |
Total current assets | 9,400 | 9,600 |
Property, plant and equipment, net | 4,370 | 4,433 |
Goodwill | 6,430 | 6,514 |
Other intangible assets, net | 5,905 | 6,079 |
Operating lease right-of-use assets | 531 | 524 |
Other non-current assets | 1,152 | 1,126 |
Total assets | 27,788 | 28,276 |
Current liabilities: | ||
Current maturities of long-term debt and finance lease obligations | 2,634 | 2,668 |
Accounts payable | 1,329 | 1,241 |
Accrued expenses and other current liabilities | 2,402 | 2,594 |
Total current liabilities | 6,365 | 6,503 |
Long-term debt and finance lease obligations, less current portion | 11,092 | 11,130 |
Operating lease liabilities | 444 | 438 |
Other non-current liabilities | 1,652 | 1,737 |
Total liabilities | 19,553 | 19,808 |
Commitments and contingencies | ||
Equity: | ||
Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2024 and 2023 | 683 | 683 |
Common stock in treasury, at cost, 173,930,493 shares in 2024 and 175,861,893 shares in 2023 | (11,130) | (11,230) |
Additional contributed capital | 6,339 | 6,389 |
Retained earnings | 16,003 | 16,114 |
Accumulated other comprehensive loss | (3,722) | (3,554) |
Total Baxter stockholders’ equity | 8,173 | 8,402 |
Noncontrolling interests | 62 | 66 |
Total equity | 8,235 | 8,468 |
Total liabilities and equity | $ 27,788 | $ 28,276 |